Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Goodwill: 2023-2025

Historic Goodwill for Cartesian Therapeutics (RNAC) over the last 2 years, with Sep 2025 value amounting to $48.2 million.

  • Cartesian Therapeutics' Goodwill changed negligibly% to $48.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.2 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $48.2 million for FY2024, which is negligibly% changed negligibly from last year.
  • Per Cartesian Therapeutics' latest filing, its Goodwill stood at $48.2 million for Q3 2025, which was down 0.00% from $48.2 million recorded in Q2 2025.
  • Over the past 5 years, Cartesian Therapeutics' Goodwill peaked at $48.2 million during Q4 2023, and registered a low of $48.2 million during Q4 2023.
  • Its 3-year average for Goodwill is $48.2 million, with a median of $48.2 million in 2025.